Decentralized Clinical Trials
iNGENū CRO is a global innovator in the conduct of multinational decentralized clinical trials (DCTs), leveraging cutting-edge technology and a patient-first approach to revolutionize the clinical trial landscape.
Key Benefits
Patient-Centric Approach
Significantly Reduced Study Burden
Cost-Effective Solutions for Sponsors
Our decentralized approach not only streamlines the patient experience but also reduces costs for sponsors. By minimizing the need for physical site visits and infrastructure, we help sponsors optimize their budgets while maintaining high standards of data quality and regulatory compliance.
Accelerated Patient Recruitment
With a wider geographic reach and the ability to engage with patients directly in their homes, iNGENū CRO’s DCTs accelerate patient recruitment, helping to meet or even exceed enrollment targets faster than traditional trial models.
Improved Retention Rates
By reducing the burden on patients and offering more flexible participation options, our DCTs significantly improve patient retention, ensuring that trials can be completed successfully with fewer dropouts.
Enhanced Diversity and Global Inclusion
Decentralized trials broaden access to diverse patient populations by overcoming geographical and linguistic barriers. Our global expertise ensures that participants from varied backgrounds are included, making study results more generalizable and reflective of real-world diversity.
Our comprehensive suite of decentralized trial capabilities is designed to meet the needs of sponsors and patients alike, delivering trials that are more accessible, efficient, and diverse.
-
eScreening
Our electronic screening process ensures that patients can be quickly and accurately assessed for eligibility without the need for physical site visits, speeding up the recruitment process.
- eConsent
We offer a streamlined, digital consent process that is compliant with all regulatory requirements, ensuring that patients can provide informed consent remotely with ease.
-
eRecruitment
Our advanced digital recruitment strategies leverage data analytics and targeted outreach to identify and engage potential trial participants efficiently, optimizing recruitment timelines.
-
Direct-to-Patient IP Delivery
Investigational products can be shipped directly to patients' homes, reducing the need for site visits and ensuring that patients have timely access to the treatments they need.
-
Telehealth Consultations
We facilitate remote consultations with trial investigators, allowing patients to receive medical guidance and support without leaving their homes.
-
Wearables for Vital Signs At-Home Data Collection
Our DCTs incorporate the use of wearables and other digital tools to continuously monitor and collect vital signs data in real time, providing a comprehensive picture of patient health throughout the trial.
-
Use of ePRO, eCOA, eClinRO Technology
Electronic Patient-Reported Outcomes (ePRO), Electronic Clinical Outcome Assessments (eCOA), and Electronic Clinician-Reported Outcomes (eClinRO) technologies are integral to our DCTs, enabling real-time data capture and analysis.
-
Efficacy Endpoint Data Routing for Central Rating and Independent Adjudication
We ensure that efficacy data is centrally routed and reviewed by independent experts, maintaining the integrity and reliability of trial results.
-
Remote, Centralized Monitoring
Our remote monitoring capabilities allow for continuous oversight of trial activities, ensuring compliance and data accuracy while minimizing the need for on-site visits.
-
High Quality, Continuous, Real-Time Data
With our state-of-the-art digital tools and platforms, we provide sponsors with high-quality, continuous, real-time data, empowering them to make informed decisions throughout the trial process.